Testing effectiveness (Phase 2)Looking for participantsNCT06418477
What this trial is testing
Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD
Who this might be right for
Monoclonal Gammopathy of Renal Significance
Peking University People's Hospital 20